NCT01238809撤回不适用
Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- AstraZeneca
- 入组人数
- 7,300
- 主要终点
- low-dose aspirin and gastroprotective treatment compliance (Girerd questionnaire: a 6-item self-administered and validated questionnaire to evaluate adherence to treatments)
研究概览
简要总结
The purpose of this study is to assess in general population low-dose aspirin and gastroprotective agent compliance and reasons for bad compliance
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •French people > 60 years old, part of Kantar Health Access Sant� panel
排除标准
- 未提供
结局指标
主要结局
low-dose aspirin and gastroprotective treatment compliance (Girerd questionnaire: a 6-item self-administered and validated questionnaire to evaluate adherence to treatments)
时间窗: One month
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in FranceHealthyNCT01211652AstraZeneca8,186
撤回
不适用
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) UlcerGastrointestinal HemorrhageUlcerNCT01215058AstraZeneca
已完成
不适用
Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using PatientsComplianceGastroprotector TherapyRisk FactorsNCT00699725AstraZeneca2,000
已完成
不适用
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mgAspirinDrug SafetyEffects, LongtermNCT01669824Bayer4,235
已完成
不适用
The Efficacy of Aspirin in the Postoperative Period in Vascular SurgeryAspirin ResistanceNCT01432652University of Lausanne Hospitals45